Skip to content

PowerSpiral Enteroscopy Performance and Safety

PowerSpiral Enteroscopy: Multicenter Prospective Study on Performance and Safety Including Patients With Altered Gastrointestinal Anatomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04884113
Enrollment
170
Registered
2021-05-12
Start date
2020-03-01
Completion date
2022-03-01
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Bowel Disease

Keywords

Motorized Spiral enteroscopy, Device-assisted enteroscopy

Brief summary

Multicenter study to evaluate the efficacy of the motorized spiral enteroscope in the management of small bowel diseases.

Detailed description

Background and Aims: Motorized Spiral enteroscopy is a recent advancement in enteroscopy. Data are scarce on the utility and safety of the motorized spiral enteroscopy. No data is available on the utility of this technique in patients with altered gastrointestinal (GI) anatomy. This study aimed to evaluate the efficacy of motorized spiral enteroscopy including rate of total enteroscopy (TER) in patients undergoing enteroscopy for suspected small bowel disease including those with altered GI anatomy. Methods: A multicenter prospective study evaluated consecutive patients with symptomatic small bowel disease who underwent enteroscopy over a 12-month period.

Interventions

Small-bowel enteroscopy for diagnosis and intervention

Sponsors

St. Antonius Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 years and older 2. Patients with suspected small bowel pathology indicated for diagnostic and/or therapeutic enteroscopy based on clinical presentation, small bowel imaging, or video capsule enteroscopy 3. Written informed consent

Exclusion criteria

1. Contraindications for endoscopy because of comorbidities 2. Unable to provide written informed consent 3. Patients with known severe gastrointestinal tract inflammation, intestinal obstruction, gastroesophageal varices or eosinophilic esophagitis that preclude a safe enteroscopy procedure 4. Coagulopathy or thrombocytopenia that could not be corrected by blood product transfusion 5. Pregnant patients 6. Health status: American Society of Anesthesiologists (ASA) class \>3 7. Inability to tolerate Propofol sedation or general anesthesia for any reason

Design outcomes

Primary

MeasureTime frameDescription
The diagnostic yield of motorized spiral enteroscopy2 daysDiagnostic yield achieved by antegrade and/or retrograde enteroscopy using motorized spiral enteroscopy
The therapeutic yield of motorized spiral enteroscopy2 daysTotal number of therapeutic interventions performed during antegrade and/or retrograde enteroscopy using the motorized spiral enteroscopy

Secondary

MeasureTime frameDescription
Total procedural time2 daysThe total time needed to complete the whole procedure of enteroscopy antegrade and/or retrograde motorized spiral enteroscopy
Total enteroscopy rate2 daysEstimate the number of total enteroscopy procedures achieved by either antegrade only or antegrade and retrograde motorized spiral enteroscopy
Adverse events7 daysTotal minor and also serious adverse events during and after antegrade and/or retrograde motorized spiral enteroscopy
Depth of maximum insertion into the small bowel2 daysEstimation of the maximum depth of insertion (in centimeters) both antegrade and/or retrograde motorized spiral enteroscopy
Technical success2 daysEstimate the rate of technically successful enteroscopy procedures both antegrade and retrograde motorized spiral enteroscopy

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026